East Coast Fever and Related Diseases: A Technical Conference by Mckelvey, J. John
- 279 - 
EAST COAST FEVER AND RELATED DISEASES: 
A TECHNICAL CONFERFNCE 
Rome, Itaily 
March 8, 1971 
- 280 - 
TABLE OF CONTENTS 
I. The East Coast Conference in Review 
(Dr. John McKelvey, Jr.) 
II. Present State of Knowledge of East Coast Fever 
(Dr. George Urquhart) 
III. Report of the Raphateur, Dr. Ordway Starnes, 
as approved by the ad hoc technical subcommittee 
(Drs. 
-- 
Cunningham, Moulton, and Starnes) 
IV. Participants 
- 287 - 
THE EAST COAST CONFERENCE IN REVIEW 
John J. McKelvey, Jr. 
An East Coast Fever (ECF) review meeting was called in order to 
gain counsel and advice from distinguished immunologists as to progress 
tha.t has been made during the seventeen months that have passed since the 
previous technical meeting was held to ascertain how far advanced is the 
research toward the goal of producing a field vaccine for ECF. This point 
bears upon the priority of ECF for inclusion among other diseases forming 
the basic program of an Animal Disease Research Center, presumably to be 
sited in Kenya. Eighteen technical and administrative people participated. 
(See attached list for the names and for the institutions these people 
represented.) 
The specific purposes of the meeting were: (a) to produce a 
concise review of the East Coast Fever situation with appended literature 
citations, fb) to try to arrive at an estimate of how soon a vaccine for 
prevention of East Coast Fever will become available, (c) to estimate how 
much additional research is required to arrive at this end, and (d).to 
place the East Coast Fever research in perspective with regard to similar 
research on trypanosomiasis. 
Dr. W. I. M. McIntyre, Professor of Clinical Medicine, University 
of Glasgow, chaired the technical discussions and called upon Dr. M, P. 
Cunningham, Project Manager, UNDP (EAVRO), concerned with East Coast Fever, 
to review the life cycle of the Theileria Parva (the causal agent of ECF) 
fo:r the benefit of those unfamiliar with this parasite, then to discuss 
his results and those of his colleagues in trying to produce a field vac- 
cine for its control. 
Dr. Jack E. Moulton, Professor, Faculty of Veterinary Science, 
University of Nairobi, commented as the discussions proceeded on the basis 
of the work that Cunningham presented. In Dr. Malmquist's absence, he re- 
ported upon growing the East Coast Fever parasite in tissue culture, (See 
attached article by Malmquist and colleagues from the Tropical Animal 
Health and Production publication, and the detailed mimeographed set of 
experiments embracing Cunningham's work, distributed for participants' re- 
view at the meeting.) 
Subsequently the meeting was opened for a general discussion of 
the status of research on East Coast Fever. 
Following the meeting Dr. G. M. Urquhart, Professor of Veteri- 
nary Parasitology, University of Glasgow, produced a concise review of 
Recent Progress in Vaccination Against East Coast Fever presented herein. 
Dr. Ordway Starnes, Director of ELAAFRO, served as rappateur of the meeting. 
His report, approved by an ad hoc technical subcommittee including -- 
Drs. Moulton and Cunningham, is appended, 
In the course of the meeting certain critical evaluations were 
expressed. Dr. E. H. Sadun, Chief, Department of Medical Zoology, Walter 
Reed Army Medical Center, recalled that 17 months ago there was some 
question whether or not the production of an ECF vaccine was possible; 
now it seems probable. However, even if sufficient knowledge existed 
for producing a vaccine by the chemotherapeutic approach, the tissue cul- 
ture or the irradiation technique, carry-over of research from laboratory 
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to field tests would take three years at least. More work needs to be 
done on cross reactions, field strains of the parasite and other spe- 
cifics. The empirical nature of immunology research on ECF, necessary 
and important as it is, needs a fundamental component that deals with 
the rationale of immunological reactions, 
Dr. George Urquhart pointed out that inoculation of cattle in 
Ilarge numbers cheaply and satisfactorily could be five to ten years 
distant. 
Dr. Moulton stressed the importance of more research on cellular 
immunity and on the investigation of drugs, among them antibiotics. 
Dr. K. H. Wilde, Senior Research Fellow, Centre for Tropical 
Veterinary Medicine, Edinburgh, pointed out the lack of information on 
the most vulnerable stage in the life of the parasite, its passage from 
salivary glands of ticks to the lymph nodes of cattle. Be, too, empha- 
sized chemotherapy as a relatively neglected area of research and he 
thought opportunities were being missed in not paying more attention to 
the carcinogenetic activity this parasite produces in the lymphocytes of 
cattle. He mentioned the need for a better understanding of the erratic 
pattern of infectivity; why cattle are sometLmes readily infected and 
other times not under an equal challenge, Dr, Wilde also raised the ques- 
tion of the profitability for a commercial drug house to produce vaccine 
for ECF once the scientific aspects of the problem had been solved, but 
believed the scientific principles involved warranted full effort in 
any case. The competitive position of a suitable vaccine was discussed 
in terms of present methods for control of East Coast Fever which depend 
upon dipping the cattle to kill the vector, the tick, 
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Dr. I. E. Muriithi, Director of Veterinary Services, Kenya, 
elaborated on costs and pointed out that a vaccine for ECF would have to 
compete with the cost for dipping each animal, which at present is at a 
level of about four U.S. cents per animal per week. 
Dr. H. C. Goodman, Chief, Immunology, WHO, called for more re- 
search on the stage in the cycle of the parasite that produced immunity; 
he stressed the importance of further work in tissue culture and of studies 
on the nature of immunity. The possibility of a variety of field strains 
of the parasite that might have a different virulence worried him and he 
thought five to ten years a conservative estimate for arriving at a practi- 
cal vaccine. 
Dr. Cunningham stated that any one of the several methods em- 
ployed today for the production of a vaccine would require at least three' 
years' additional investigation before it would prove to be practical. 
Dr. William Payne, Consultant for UNDP, announced that he had 
just received a telegram from Ralph Townley, UNDP in New York, indicating 
that funds available under the UNDP/SF project governing the research on 
ECF received an extension of availability from the UNDP governing council 
from 1972, when they are due to expire, until 1974. 
Dr. McIntyre, calling upon Dr. Cunningham in particular but also 
upon the group as a whole, identified eleven broad lines of research which 
would help remove the impediments to success in arriving at a vaccine for 
ECF: 1) irradiation variables, 2) use of drugs and their application at 
proper dosages, 3) bulk production in vitro of g. parva infected cell lines -- 
for vaccines, 4) harvesting the infective stage of ga parva from tick salivary 
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glands and, associated with this method, grinding up ticks, 5) isolating 
the parasites from ticks and growing them in tissue culture, 6) field 
epidemiology - the role of related strains of parasites and related diseases, 
7) studies on the acceptance of certain cell lines of parasites in cattle 
hosts, 8) studies on the mechanism of immunity, 9) preservation of live 
vaccine, 10) developing other antigens, for example, using dead instead 
of live parasite material, 11) studies on the virulence of different strains 
of parasites. 
Four to five of these lines of research Dr. Cunningham and his 
colleagues are already pursuing with great success, but it was the consensus 
of the meeting that a broader approach to the problems of producing a vac- 
cine would be even more productive. 
Dr. Sadun then discussed his own work at Walter Reed Hospital on 
trypanosomiasis and the success that has been achieved in irradiation 
techniques to vaccinate animals to combat trypanosomiasis. His work dealt 
with four species of trypanosomes - brucei, Kambiense, rhodesiense, and 
congolense. Dr. Sadun suggested that the work on East Coast Fever and 
trypanosomiasis had many points in common; a high-powered group of immunolo- 
gists working on East Coast Fever could readily apply their skills and 
knowledge to work on trypanosomiasis and vice versa. 
Dr. John McKelvey, The Rockefeller Foundation, introduced a proposi- 
tion as follows: a) that it was imperative for the Cunningham research pro- 
gram to receive full support, b) that irrespective of whether this research 
would continue to be located in EAVRO or elsewhere a need does exist for an 
Animal Disease Research Center of the sort being proposed, c) that one half 
- 286 - 
or perhaps three fourths of the research toward vaccine production for 
ECF has been accomplished but to complete the final stages of this re- 
search will probably require five to ten years, d) that ECF research as 
placed in the proposed Center is still of highest priority as a short- 
term program, and e) that following the solution of ECF, trypanosomiasis, 
a long-term problem, should then receive highest priority. 
Dr. Sadun corrected the statement about trypanosomiasis and in- 
dicated research on both diseases should progress simultaneously. As 
corrected the proposition stood with the consensus of the participants. 
Dr. M. Abdussalam, Chief, Veterinary Public Health, WHO, sug- 
gested that cystercicosis ought not to be ignored. The participants 
seemed agreed on this point as well as on Dr. Sadun's above point. 
All of the participants expressed their admiration of Dr. Cunningham 
and his colleagues for the enthusiasm and the skill with which they have 
worked and for the success of their investigations. 
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II 
PRESENT STATE OF KNOWLEDGE OF EAST COAST FEVER 
George Urquhart 
Introduction 
East Coast Fever, a tick-transmitted 
and Central Africa, is caused by the protozoan 
disease of cattle in East 
parasite Theileria parva. 
It is one of the major lethal diseases of cattle and has been given top 
priority in the United Nations assessment of the research needs of East 
Africa (East Africa Livestock Survey, 1966). In non-enzootic areas (i.e. 
areas where the tick vector Rhipicephalus appendiculatus occurs only 
sporadically) mortality may approach 100%; in enzootic areas upgrading of 
livestock is almost impossible since high-grade cattle cannot be intro- 
duced. There is no vaccine against the disease and no cure is available 
once the disease is established. At present control, in areas where this 
is feasible, depends on repeated dipping or spraying of livestock at 
frequent intervals, e.g. initially every three days. 
Background to the Current Development of Vaccination Techniques 
It is generally agreed that a practical form of immunisation 
would be the most significant single means of combatting the disease and 
an examination of the facts, as at aresent established, gives every indi- 
cation that such a vaccine would indeed be successful. Thus recovered 
animals do not become carriers (i.e. support a low-grade blood infection 
,which, although clinically non-apparent, leads to the infection of suc- 
cessive generations of ticks) but possess a sterile immunity which is 
life-long. Also there is no evidence as yet that more than one immuno- 
logical strain of 2. parva exists and this if confirmed simplifies im- 
mensely the preparation of a vaccine. 
Despite these.encouraging portents no practical technique of 
immunisation is yetdeveloped. To appreciate the scientific reasons why 
this has not been possible it is necessary to outline the essential 
features of the life-cycle of the disease, some of which have only been 
. 
established in the last 2 years. 
When cattle develop the clinical disease a large proportion of 
the red blood cells contain East Coast Fever parasites; the latter have a 
characteristic appearance and are generally referred to as 'gametocytes'. 
Immature stages of the tick R. appendiculatus which ingest blood 
meals during this time become infected with the gsmetocytes. The tick 
drops off the infected animal on to the ground, develops to the next 
stage and subsequently, some weeks later, becomes attached to another 
bovine for a further blood meal. During the course of this meal large 
numbers of East Coast Fever organisms derived from the gsmetocytes develop 
in the salivary glands. These are structurally different and are called 
'sporozoites'. The.sporozoites are injected with the saliva into the new 
host and pass to the nearest lymph node (usually the parotid node since the 
ear is the preferential site of tick attachment) where they infect mono- 
nuclear blood cells called lymphocytes. The parasites, now recognisable 
as structures called schizonts multiply rapidly and soon.reach all the 
lymph nodes and proliferate rapidly in.all the available lymphocytes. 
By this time the animal is clinically ill but some dqys before 
death a proportion of the schizonts become altered in appearance and give 
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rise to the gametocytes described earlier. These leave the lymphoid 
tissue and infect the red cells. The gametocytes do not multiply in the 
red cells their future development being dependent on being ingested by 
a suitable tick. 
Early work in attempts to develop immunisation procedures have 
shown that the injection of the gametocytes does not confer immunity. 
The next most readily available sources of antigen, i.e. materials which 
possess the potential to stimulate immunity, are the schizonts found in 
massive numbers in the lymphoid tissues of terminal cases. Inoculation 
of these to stimulate immunity have been attempted on a number of occasions 
(see review by Barnett, 1968). The general result of these experiments 
was that while a variable proportion of animals were successfully im- 
munised, others died of East Coast Fever induced by the immunising inocula- 
tion, while the remainder were unaffected by the inoculation but were 
completely susceptible to subsequent challenge with infected ticks. Proba- 
bly there are two reasons why this technique was unsuccessful: first, 
the innate variation in susceptibility of individual cattle to any given 
dose of schizonts; secondly, the possibility that in a proportion of 
cattle the lymphocytes were 'rejected' and the parasites unable to 
develop in their new host. 
Current Developments in Vaccine Development 
Since this work was completed there have been four major ad- 
vances which have improved immensely the possibility of immunisation. 
In 1.969 Jarrett, Crichton and Pirie published a paper dealing 
with the rate at which schizonts proliferate in infected cattle and the 
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relationship of this to the size of.the infecting dose (i.e. the number 
of ticks), the onset of clinical signs and the development of immunity. 
They showed for example that the schizonts typically increased ten-fold 
every 3 days and that fever occurred when they numbered around 7 x 10' 
and in their discussion demonstrated how these and other facts might be 
utilised in immunological studies. 
The second advance was the development by Cunningham and his 
colleagues (private communication at Rome, 1970) of two techniques for 
the isolation and storage at low temperatures of sporozoites collected 
from ticks. Until this point immunisation or challenge to cattle with 
sporozoites had necessitated the use of batches of ticks of varying and 
unquantifiable degrees of infectivity. As a result of their work it is 
now possible to store.at low temperatures a large volume of material 
containing infective sporozoites of known potency. Their present work is 
being directed towards the possibility that the injection of a small 
number of sporozoites - smaller than the dose injected by one tick - would 
enable the animal to develop an acquired immunity before its lymphocyte 
population is seriously depleted and clinical signs and death supervene, 
i.e. although the schizont population may increase ten-fold every 3 days, 
the initial dose should be small enough to delay the appearance of clinical 
signs and allow the immune response to develop., This, according to Jarrett 
and his colleagues, might require at least 3 weeks. 
Cunningham and his colleagues have indicated that variations in 
the susceptibility of.individual cattle may make this objective difficult 
and that a larger number of sporozoites attenuated by a suitable dose of 
cobalt irradiation might prove more efficacious. After irradiation it 
is possible that the rate of the replication of schizonts might be 
slowed or even halted at some point after inoculation. At present ex- 
periments are in progress on both of these lines but it is premature to 
assess their ultimate success. 
The third significant advance has been recently reported by 
Malmquist, Nyindo and Brown (1970) who have successfully cultured in - 
vitro (i.e. -- - in glass vessels) the schizonts of 2. parva in multiplying 
cells originally removed from the spleen and lymph nodes of cattle 
infected with the disease. This has been previously claimed by other 
workers but it is generally agreed that this is the first unequivocal 
demonstration of successful culture and z. parva infected cell lines 
:have been maintained in their laboratory for 10 months. 
Although in the past schizonts have been used for vaccination 
experiments they have had to be obtained in limited numbers from a 
variety of diseased animals, any one of whom might also be infected with 
other diseases transmissable by inoculation. The significance of 
Malmquist and his colleagues' work is that unlimited numbers of schizonts 
are now available from a single controllable source for evaluation in 
vaccination experiments. As with the projected sporozoite,vaccine the 
problems are first, the determination of the right dose and secondly the 
possibility that some form of attenuation might be necessary. Neverthe- 
less the availability of schizonts in this form is an immensely encouraging 
advance in these initial stages of vaccine development. 
The final development,has been the results of the most recent 
work on the use of tetracyclene drugs to facilitate immunisation. It 
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was shown by Neitz (1953) and by Barnett (1956) that chlortetracyclene, 
administered continuously for 30 days after infected ticks were placed 
on an animal, largely suppressed the overt disease and rendered cattle im- 
mune to subsequent challenge. This technique was of course not applicable 
as a large scale immunisation procedure. Subsequently in 1969 Jarrett, 
Pirie and Sharp showed that chlortetracyclene was effective even if 
discontinukd as early as the eighth or sixteenth day. Since then 
Cunningham and his colleagues (private communication at Rome, 1970) have 
shown that infection introduced by inoculation of sporozoites which had 
been preserved at low temperatures combined with tetracyclene on two oc- 
casions (i.e. the day of inoculation and the subsequent day) induce a 
very high degree of resistance to challenge. Further developments in 
this field should be interesting and if inoculation of a given number of 
preserved sporozoites or perhaps cultured schizonts, combined with a single 
dose of antibiotic administered on the same occasions, gave an acceptable 
degree of immunity, a practical method of vaccination could be said to 
be available. The single reservation might 
antibiotic. 
Conclusions 
There is no doubt that the [four] 
perhaps be the cost of the 
advances described above, 
i.e. the development of techniques for quantitating the kinetics of 
parasite multiplication, the successes in the preservation of sporozoites 
and the culturing of schizonts, and the advances in chemoprophylaxis have 
brought forward rapidly the time whena successful method of practical 
vaccination will be available. The main problems which have still be to 
surmounted are: 
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a) As yet none of the present techniques prevent the 
development of tick-infective forms, i.e. gametocytes 
in the red cell. This might limit the use of such 
vaccines under a range of circumstances. 
b) The experiments to date have necessarily utilised 
small groups of cattle. While the death of 1 in a 
group of 10 immunised bovines is a signal advance in . 
an experiment in which all 10 controls have died, this 
does not necessarily imply acceptability in the field, 
where a 10% mortality due to vaccination would be 
viewed with considerable reservation (probably 1% would 
be acceptable). 
c) The cost of such a vaccine and techniques for distribu- 
tion are of particular importance in the areas where it 
would be used and are still to be developed. 
d) Field testing of developing vaccines 
undertaken and there is little- doubt 
bring new problems. 
has still to be 
that this will 
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I III 
REPORT OF THE RAPPATEUR 
(Dr. 0. Starnes) 
, 
AS APPROVED BY THE AD HOC TECHNICAL SUBCOMMITTEE 
(Drs. Cunningham, Moulton, and Starnes) 
SUMMARY AND CONCLUSIONS 
The present status of research and development work on East 
Coast fever under the UNDP/SF Project 300 entitled Immunological Research 
on T ick-borne Cattle Diseases and T ick Control tunderway in the EAVRO, the 
USDA cooperative research on East Coast fever at the same location and 
work underway in the Faculty of Veterinary Science, University of Nairobi, 
and related work is reviewed. 
Progress is reported in the understanding of the epidemiology of 
the disease; techniques have been developed for the harvesting of the in- 
fective stage of the parasite from.ticks; for the viable preservation of 
the parasite at low temperature; for the production of reproducible infec- 
tion in-cattle by inoculation and for the in vitro ma intenance of & parva -- 
infected cell lines. 'Using these,new techniques, four experimental methods 
for vaccinating cattle against ECF have been investigated. 
The results of field investigations suggest that immunological 
variants of-L parva exist, and that other Theilerial species may be in- 
volved in the East Coast fever syndrome. 
W h ile results are encouraging the underlying reasons are not well 
understood. 
Priorities for future work include: 
1. Irradiation variables. 
2. Chemotherapy studies. 
3. Bulk production in vitro of x. parva 
4, Harvesting the infective stage of 2. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
The 
The viable preservation of all stages of 2. parva, using 
freeze drying and cryopreservation techniques. 
Antigenic analysis of g. parva. 
Pathogenesis of ECF in cattle. 
Development of x. parve\. in &. appendiculatus. 
effort required on these problems indicates the need for 
concerted, sustained effort over a period of at least ten years in which 
ticks. 
The in vitro culture of tick tissues -- 
of g. parva. 
infected cell lines. 
parva.from infected 
and developmental stages 
Field epidemiology - the role of related strains and related 
diseases. 
Histocompatability studies. 
Mechanisms of immunity. 
time it is considered that a practical solution to East Coast fever will 
have been,found and that substantial progress will have been made in the 
immunology of trypanosomiasis. 
Introductory Comments 
The meeting was convened by McKelvey of the Rockefeller Founda- 
tion at 0950 on 8 March in the India Room, FAO Headquarters, Rome and 
Chaired by McIntyre of Glasgow University. 
Participants were welcomed by White of FAO who conveyed greetings 
on behalf of FAO's Director General, Dr. Wells and of the Director of the 
Operations Division, FAO and expressed on their behalf keen interest in 
the subject under discussion. 
McKelvey expressed his appreciation to participants, conveyed the 
apologies of Dr. MaBnquist, USDA Scientist working on ECF at Muguga who was 
unable to be present, and recognised Dr. Malmquist's contribution of two 
papers of interest to participants. He expressed the regrets and apologies 
of Dr. Pino, Director of Agricultural Sciences, Rockefeller Foundation and 
conveyed Dr. Pino's wish that conclusions reached at this meeting convey 
priorities for future work and that the record be appropriately documented, 
McKelvey then reviewed previous discussions on this subject and 
indicated that the objective of this conference is to confirm the present 
status of research end development work on ECF and to clearly outline what 
additional research is required to achieve effective control of the disease. 
He then introduced McIntyre and requested that he Chair the meeting. 
McIntyre recognised the principals who would be presenting in- 
formation on the current status of ECF work. He then introduced Cunningham, 
Manager of UNDP/SF Project on "Immunological Research on Tick-borne Cattle 
Diseases and Tick control" and invited Cunningham to present a status re- 
port on this project and related work. 
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Present Status - UNDP/SF Project and Discussion Thereon 
Cunningham recognised contributions by Moulton and others of the 
Faculty of Veterinary Medicine, University of Nairobi, Dr. Malmquist of the 
USDA and others to the total effort- including that of the UNDP team. 
The following is taken from Cunninghamts notes which he later 
reproduced and distributed to participants. 
East Coast fever is a tiek-borne disease of cattle in East and 
Central Africa caused by Theileria parva. While other theilerial parasites 
are commonly found in wild and domestic ungulates, x. parva affects only 
domestic cattle and buffalo. 2. parva is transmitted by Rhipicephalus s- 
pendiculatus. This is a three host tick: eggs hatch to larvae - nymphs - 
adults. If either larvae or nymphs.feed on an infected cow, the succeeding 
nymphs or adults will then be-infective for cattle. The development of the 
parasite in the tick is not understood, but in the unfed infected tick, the 
parasite,is found in the acinar cells of the salivary gland. At this stage 
theparasite is not -infective for cattle. When the tick starts feeding the 
parasite undergoes a cycle of maturation and maximum numbers of mature in- 
fective particles (IFS) are excreted in the saliva between the 3rd and 5th 
days of attachment. 
When a susceptible animal is fed on by infected ticks, an indefinite 
number of IPs are inoculated over an extended period. The macroschizonts of 
the parasite first appear in lymphoid blast cells from the local drainage 
lymph node (since the preQile&ion~sfte of attachment of the tick is the 
head and ears of cattle, the parotid lymph node is regarded as the local 
- 299 - 
drainage lymph node). The macroschizonts proliferate throughout the 
lymphoid organ and around the 14th day after tick attachment some of the 
macroschizonts switch to microschizonts - host cells disrupted, parasites 
are released and invade red blood cells. This process is continuous, al.1 
stages of the parasite continue to increase in numbers (although only the 
macroschizont is known to multiply) until the animal dies. 
Jarrett found that by infecting cattle with increasing numbers 
of ticks, the prepatent period and time to death was reduced. He found 
the replication rate of the parasite however to be constant, whether 10 or 
1000 ticks produced the infection. 
Morbidity and mortality in susceptible animals exposed to infec- 
tion approaches 100%. No curative drug is available and the only method 
of controlling the disease is the continuous application of acaricides at 
very close intervals, as little as three days to prevent attachment of 
infected ticks, Obviously an effective drug or a vaccine would be of value. 
The UNDP supported project is investigating the feasibility of vaccinating 
cattle against ECF. That this should be possible is supported by the ob- 
servation that in enzootic areas, where calf mortality ascribed to ECF can 
be,as,high as 30%, surviving cattle have naturally acquired an immunity 
against ECF. 
Past workers have .used three main approaches in attempts to 
immunise cattle against ECF, 
The first method - inoculation of macroschizonts harvested from 
reacting cattle into susceptible cattle. This method was used on a large 
scale in the Transkei at the beginning of this century (Theiler, 1912, 
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Spreull, 1914). Between 200,000 and 300,000 cattle were inoculated 
with-suspensions prepared from spleens and lymph nodes taken from in- 
fected cattle. Approximately 25% of the inoculated cattle died, and 
approximately 75% of those surviving the inoculation withstood natural 
challenge. Comparable results were obtained by later workers using 
smaller numbers of cattle, although some workers, for example Walker and 
Whitworth (1930), reported 100% success with suspensions obtained from 
particular individual cattle. Jarrett, Crichton and Pirie (1969) estimated 
the numbers of parasites theoretically required to immunise cattle and con- 
firmed their estimates in a small number of cattle. Without doubt cattle 
can be vaccinated by this method but it is unlikely that progress can be 
made until large numbers of parasites can be grown in vitro. -- 
The second method - infection and treatment. Neitz (1953) found 
that when infected ticks were applied to 7 cattle which were simultaneously 
treated with Aureomycin, the cattle underwent mild reactions and were im- 
mune onchallenge, The drug was administered intravenously at a dosage rate 
of10 mg./kilo,starting 24 hours after tick infestation and continuing on 
approximately alternate days for 2-S weeks. Neitz also reported the ef- 
ficacy of Terramycin used.in the same manner. This was confirmed by 
Jezierski, Lambelin and Lateur (3.959) in the Congo. Later, Barnett, Bailey 
and Bracklesby (1965) found that daily,oral administration of Aureofac (and 
other related drugs) to infected tick infested cattle for 28 days produced 
immunity comparable to that produced in cattle naturally recovered from ECF. 
Jarrett, Pirie and Sharp (1%9), using Aureomycin orally at a 
dosage rate of 16 mg./kilogram found that 10 daily treatments markedly 
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suppressed the reaction, while 18 daily treatments gave complete sup- 
pression and subsequent immunity. 
Other workers (Robson, Yeoman and Ross, 1961, Roe, 1962 and 1962a, 
Stobbs, 1964) treated cattle orally with Aureofac while exposed to natural 
infection. In order to produce immunity, however, continous daily treat- 
ment for as long as 3 months was required. 
Again, this method can be used to immunise cattle against ECF, 
but is impractical because of expense. It was considered however that if 
reproducible ECF infections could be produced in cattle by inoculation, it 
might be possible to reduce the dose of drug required and the duration of 
its administration required to immunise. 
The third approach - the "Quantum of infection hypothesis" put 
forward by Wilde et al. :1968). This is based on the observations of Lowe -- 
(1932) in Tanzania that under climatic conditions unfavourable to tick sur- 
vival, there was a reduced calf mortality to ECF. Lowe thought that the 
reduced mortality could be attributed to the small numbers of ticks feeding 
on the calves. Lewis (1950) reported that infection rates in ticks became 
reduced with age, and that old ticks were more likely to produce mild re- 
actions in cattle. Wilson (1950, 1950a and 1951a) found that when the number 
of infected ticks applied to catLIe was limited, increased numbers of mild 
reactions, with recovery and subsequent immunity, were observed. Barnett 
(1957) suggested a direct relationship between numbers of IPs inoculated 
and the severity of the ensuing reaction but decided that since one infected 
,tick could kill a susceptible animal, the approach had no practicality. 
Wilde et a1.(1968) however found that the infective stage of the parasite -- 
could be obtained in suspension from the salivary glands of partially fed 
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ticks; that cattle could be infected by inoculation; and that the parasite 
survived freezing to approximately -7O'C and retained its infectivity for 
cattle. 
When UNDP started its project all this information was available; 
the Wellcome and the Glasgow groups afforded every assistance to the TJJDP 
researchers, including unlimited access to unpublished work. 
At the outset, we considered that to investigate any or all of 
the three approaches it was necessary to obtain suspensions of IPs which 
would regularly infect cattle by inoculation, which could be preserved 
alive at low temperature, and whose infectivity could be established by 
titration. 
If this were possible, we would then be in a position to: 
1. Investigate the quantum of infection hypothesis, 
2. Improve on the infection and treatment approach. 
3. Investigate the effects of irradiation on IPs. 
In addition we set out to grow the parasite in tissue culture - 
might.be-able to substitute test tubes for cows, and tissue culture schizonts 
might prove better than freshly collected material for immunisation. 
The achievement of these objectives was described at the Bellagio 
Conference held in October 1969. One of the difficulties encountered, which 
was described in detail at the last conference, and which is relevant to 
today's presentation, is as follows: When ticks are induced to salivate 
into-whole bovine blood (Purnell and Joyner, 1967, and Purnell et al., 1969) 
the suspension, containing parasites, will regularly infect the donor ani- 
mal or its monozygotic twin, but does not infect unrelated homologous 
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animals. Similarly with the macroschizont from an infected animal. Small 
numbers of macroschizonts will infect a monozygotic twin, but not unrelated 
homologous animals. We consider it likely that once the parasite becomes 
associated with the host cell, the establishment of the parasite in another 
animal is dependent on the acceptance of the host cell. This phenomenon 
may explain the divergent results obtained in attempts to immunise cattle 
by inoculation of macroschizonts. 
Following some discussion on problems associated with the produc- 
tion of infected ticks, diluents for the parasites harvested from ticks, 
the preservation of the parasite at low temperatures, McKelvey referred 
further to Dr. Pino's request that participants seek to quantify the status 
and outlook of ECF on the basis of: 
1. Citations to pertinent literature. 
2. Is a satisfactory solution to ECF (vaccine) 
now available? 
3. How far are we from a solution? 
4. What are the prospects? 
5. What is required to achieve a satisfactory vaccine? 
6. In relation to ECF what emphasis is indicated for try- 
panosomiasis, i.e. are we one-third, one-half or three- 
quarter towards a solution to ECF with the expectation 
that a team if mounted on ECF would continue on try- 
panosomiasis. 
Cunningham then continued his presentation on four methods 
of vaccination. 
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1. The Quantum of Infection Hypothesis 
He referred to experiment FAO 36 in Appendix 1. Following 
his presentation and some discussion on results obtained Cunningham con- 
cluded that these results support the quantum of infection hypothesis. 
However, it was considered that this approach is unlikely to be productive 
of a practical method of vaccination. 
2. Effect of Irradiation 
Cunningham referred to FAO 40, 45 and 46 Appendix 1 and following 
discussion observed that a vaccine using the right concentration of parasites 
exposed to the right radiation dose will immunise cattle. 
Moulton enquired as to the effect of radiation on the parasite. 
Urquhart replied that in his experience with other organisms, radiation 
stopped the development of the organism. 
Moulton considered that parasite replication is inhibited by 
irradiation. Sadun added that in his experience there is a relationship 
between numbers of parasites inoculated and the resulting immunity. 
Goodman commented that the Cunningham data indicated that repli- 
cation did continue, although inhibited. 
3. Infection and Treatment 
Cunningham referred to FAO experiments 48, 50 and 55, Appendix 1, 
commented on the data and concluded,that with the use of Reverin at a dosage 
rate of 5 mg/kilo intramuscularly, considerable improvement over previous 
results had been obtained. 
Moulton suggested further work with actinoqctin D as this anti- 
biotic was highly effective in inhibiting lymphoblasts in tissue culture 
and he stated that at the Faculty of Veterinary Science they cured a case 
of ECF with the drug. 
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McKelvey posed a question as to the significance of use of drugs 
in relation to vaccine development. Moulton in response said the drug is 
to suppress the population of parasites and thus to facilitate employing 
the vaccine subsequently. Goodman agreed that the use of the drug was com- 
plementary. 
At this time copies of a reprint entitled "East Coast fever: 
Cultivation in vitro of Bovine Spleen Cell Lines infected and transformed -- 
by T. parva" by Malmquist and others were distributed. Also a multilithoed - 
paper entitled "United States Department of Agriculture - Cooperative Re- 
search on East Coast fever" by Malmquist was distributed. Moulton summarised 
these in relation to previous discussion. 
Cunningham considered that there is every reason to believe that 
the parasite can be grown in large quantities. He then drew the attention 
of participants to results of tissue culture experiments FAO TC 4 - TC 14. 
Goodman enquired as to whether the difficulty in infecting un- 
related homologous cattle is a principal issue in relation to the tissue cul- 
ture derived parasite. 
Cunningham said that there is not enough evidence to tell in this 
particular case. 
Goodman then enquired of Cunningham as to what variables now need 
be resolved to establish the cell line approach to vaccine production. 
Cunningham replied that the results of each experiment determines the next 
step to be taken. 
Urquhart inquired about differences in results reported in ex- 
periments TC 4 and TC 7. Cunningham pointed out that the 15th passage of 
the C 2 cell line was used in TC 4, while the 58th passage was used in TC 7. 
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Also, concentration of foetal calf serum (FCS) was reduced in TC 7. He 
then drew attention to the longevity of immunity of cattle recovered from 
experimentally induced ECF (Appendix 1). 
With consideration to issues yet to be resolved Cunningham noted 
the possibility of the occurrence of multiple strains of 2. parva citing 
experiments conducted at Aitong, Kenya, where two types of parasites were 
found, one being similar to 2. parva (Muguga)) and the second being quite 
different. Malmquist found that these strains also performed differently 
in tissue culture. GOOdman asked whether it is conceivable that another 
vector is involved. Cunningham replied that attempts to transmit these 
strains through 5. appendiculatus and through E. evertsi had failed. 
Abdussalam enquired as to whether it is known whether there are 
different strains of x. parva at Muguga. Although not in direct response 
to the question Cunningham cited other cases in which apparently different 
strains were encountered, Muriithi added that he considers that there are 
two types of ECF even in the absence of buffalo. 
Following lunch the Chairman charged participants to give clear 
definition to problems and to the need for further work while continuing 
the technical discussion. 
McKelvey briefly reviewed previous discussions concerning con- 
straints affecting the further development of ECF work within existing in- 
stitutions. These constraints include limitations on freedom of action, 
of ability of the institutions to attract and retain top flight scientists, 
and to respond quickly to new. research opportunities. These constraints 
on existing institutions have led to general agreement on the need for 
another institution which would be free of such constraints. Envisaged 
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is a new institution capitalised at perhaps 3.5 million with recurrent 
costs of approximately one million dollars per annum, it is considered 
that no one donor agency would seem prepared to support a development of 
an institute of this magnitude alone. Therefore consideration is being 
given to possible interest on the part of a consortium of donor agencies 
who might undertake the project. This concept was well received at the 
Bellagio meeting of representatives of donor agencies held in April 1970. 
Following the Bellagio meeting consideration was given to an appropriate 
base for such an institution. It was deemed desirable that the institu- 
tion be established near Nairobi in bilateral arrangements with the Govern- 
ment of Kenya. Prior to arriving at this conclusion careful consideration 
was given to other alternatives including basing such a program in EAVRO 
at Muguga, and also in the Faculty of Veterinary Medicine, University of 
Nairobi. In the course of these deliberations two basic questions arose: 
first, since UiDP has a program at Muguga why not integrate the proposed 
work into EAVBO, and second, since so much progress has been made on ECF 
what justification is there to predicate an institute on ECF and related 
problems? 
In response to the first question, the consensus was that a 
bilateral arrangement with the Kenya Government seemed to be the best ap- 
proach as conditions obtained in the early planning of the proposed insti- 
tute. Additionally, it was noted that contact has been established with 
the East African Community; the Community has been invited to offer the 
same concesssions promised through a bilateral relationship with the Govern- 
ment of Kenya. Should the EAC be in a position to offer comparable con- 
cessions there would be then a basis of discussing the establishment of the 
proposed institute in the Community. 
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Following the meeting of the consortium referred to earlier a 
conference was held with representatives of the French, ODA of the United 
Kingdom, FAO and USAID. At this meeting a proposal for an international 
effort on livestock production, and its relationship to this concept of 
an animal disease institute was discussed. It was considered that there 
should be a close relationship between the two proposed institutes but that 
action to mount the Animal Disease Research Institute should not be held in 
abeyance pending the outcome of further discussions on the parent Livestock 
Production Institute which is suggested for siting in West Africa. 
EAVRO has and will continue to have its own research program on 
XCF; the development of an Animal Disease Institute in East Africa should 
not adversely affect this because of the specialised nature of work proposed 
for the Institute, concluded McKelvey. 
Sadun expressed interest in the type of personnel who would be 
involved in the proposed Animal Disease Research Institute program, and 
specifically in the possibility of seconding people currently involved in 
this area of work elsewhere to the Institute's program including personnel 
from his program. 
Abdussalam requested clarification on the bilateral aspects of 
the proposed institute. McKelvey replied that the institute's international 
role might be achieved through the involvement of nationals of various coun- 
tries in the institute's program both as staff and as trainees. With ref- 
erence to financial support he considered it would be desirable to have as 
many as four donor agencies underwriting the capital and recurrent costs of 
the proposed institute over a period of 10 to 14 years. 
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Griffiths said he was aware of discussions with EAVRO relative to 
the projected ECF program, but asked whether there had been discussions with 
EElTRO in relation to the site of the proposed institute? McKelvey noted that 
discussions had been held with Director Rashid of EAVRO and with other Community 
officials but not specifically with those at EATRO. 
Griffiths enquired as to whether it is considered that the establish- 
ment of the proposed Animal Disease Institute would mean greater competition 
for funds. McKelvey cited the favourable effect of the establishment of the 
International Rice Research Institute on the expansion and strengthening of 
national rice research institutions. Sadun commended the "built-in redundancy 
features" of the proposed institute and cautioned against placing complete re- 
liance for such important research matters as ECF and trypanosomiasis on any 
existing single effort. 
Muriithi referred to the lack of understanding behind some of the 
results reported and noted that it is vital that the reasons behind the ex- 
perimental results obtained be understood, and that to do so will require con- 
certed sustained effort. 
Wilde referred further to the competitive role of the proposed insti- 
tute and concluded that there will be competition between the proposed and ex- 
isting institutions for resources and staff, and that the proposed institute 
would, in his view, hazard the present activities in the present problem areas 
of ongoing institutes. 
McIntyre, Sadun and McKelvey cited additional cases in which the 
development of an additional institute and program has resulted in the strength- 
ening of the existing institutions. 
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Moulton enquired as to whether the proposed institute would have 
a responsibility to train Africans at the postgraduate level. McKelvey re- 
plied in the affirmative and indicated that this would be in conjunction with 
existing educational institutions. Goodman added that the training element 
would be an important wsy of strengthening other existing institutions and 
that the institute should otherwise demonstrate leadership through the of- 
fering of conferences, symposia and short-term specialised training programs, 
all of which would be mechanisms for strengthening other institutions. He 
suggested also consideration of the possibility of building into the proposed 
institute a mechanism for grant support of work in other involved institutions, 
Ansari observed that participants had discussed two problems, firstly, 
the technical aspects of ECF and had concluded that certain research and train- 
ing should be in one institution and, secondly, the possibility of competition 
between the proposed and existing institutions for staff and other resources. 
He concluded that a decision should be made as to whether the proposed insti- 
tute would be concerned primarily with fundamental or problem oriented re- 
search which decision will influence the type of institute required. 
White enquired into the sort of continuity projected for the proposed 
institute. He reminded participants that the present UNDP project is only pro- 
jected through December 1972.. He added that it may be very difficult to win 
a further extension of the project beyond December 1972, unless it is possible 
to convey to UNDP the likelihood that the program will be continued on a regional 
or global basis. Responding the Chairman indicated that he considered that the 
strongest possible justification should be advanced for continuity of the on- 
going UNDP/SF project. 
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The Chairman again requested participants to give further de- 
finition to problems and invited certain participants by name to express 
their views. 
Sadun - noted that in the interim since the last meeting much more 
basic information and data has been generated in support of the general 
position reported at the earlier meeting. Of the results presented on tis- 
sue culture, on chemotherapy and on irradiation it is still not possible 
to say which approach promises the solution. What really is happening be- 
hind the observed results? The quantitative aspects of irradiation need 
to be worked out and much time will elapse before that information reported 
here can be employed in the field. 
Relapse variance needs more attention, Would a vaccine if available 
be effective against variants? This aspect needs quantification and quali- 
fication. Vaccine development work should not be delayed pending snswers 
but these questions must be answered. 
Urquhart - the problem of quantity of antigen need 
noting that too frequently the animal dies before developing 
be clarified 
immunity. What 
are the dosage safety margins in relation to differential response by animals? 
He observed that the tissue culture work looks much more promising than at the 
time of the earlier discussions. He suggested the desirability of going into 
field trials as a basis for identifying field treatment problems. How practical 
are the presently available experimental vaccines for field control? What 
level of mortality associated with vaccination is acceptable? What might be 
the reasonable cost of producing a vaccine? 
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Wilde commented that the FAO/UNDP team work is excellent and 
that they have made more progress in the period than he had expected. 
The most important area in which knowledge is required is con- 
cerning the period from the beginning of development of the parasite in 
the tick to the onset of response observed in the lymph nodes. It is in 
this period that the parasite is vulnerable in the host. It is in this 
period also that the parasite is vulnerable to chemotherapy. The knowl- 
edge that this is the vulnerable period accrued from the UNDP project 
effort, 
Wilde noted that Cunningham has postulated that individual 
animals may be able to program the disease differently. He concluded by 
suggesting that the research at Muguga justifies expediting this work in 
every possible manner, and that he is optimistic as to its outcome. 
Goodman - noted that in the results reported solid immunity to 
ECF is shown. The in vitro culture work is deserving of considerably more -- 
emphasis. Tissue culture results open other areas requiring additional 
work, including: whether or not viruses are present in the lymphoblasts, 
what do the antibiotics do to the parasite, what is the mechanism of 
immunity, how much of the immune reactivity is destroyed when the animal 
becomes immune? 
The Aitong field study points toward discovery of different 
strains of 2. parva; other such problems will arise when the work is ex- 
panded in the field. 
Muriithi - every effort should be made to identify the main 
immunogenic strains with the objective of developing a broad spectrum vac- 
cine. The solution may be ten years away, but we cannot affort to lose 
any time. 
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In response to the earlier question as to mortality to be 
tolerated following vaccinatioa Muriithi noted that mortality following 
vaccination of 1 to 2% would be considered tolerable, but the goal is, 
Iof 'course, zero mortality. 
Dr. Muriithi - noted.that control is now achieved by dipping 
cattle at a cost of about 25 to 30 E.A. cents per animal per week. This 
is a lower limit to aim for. Foot and mouth disease vaccine costs are 
4 to 5 E.A. shillings per year - a reasonable guide. Muriithi concluded 
'by suggesting that investigators ought to examine certain practices the 
nomadic people use to treat cattle with local remedies. 
Abdussalam - suggested attention to the lag period between 
laboratory work and field use. 
Griffiths - noted that there are now three sub-projects asso- 
ciated with the U!.VDP/SF project at Muguga, these being the Kenya project 
which is now active and two proje,cts, one in Tanzania and the other in 
Uganda, which are to be activated during this year. Each of these projects 
offer outlets for findings accruing to the Muguga effort. 
.Moulton added the following to the list of problems for study: 
1. A search for a toxin which might be associated with the 
disease; 
2. Investigations on the sudden death of infected lymphoblasts; 
3. Humoral versus cellular immunity; 
4. Identification of other ECF strains; 
5. How the parasite converts the host cell to a neoplastic-like 
cell; 
6. Chemotherapeutics; 
7. White blood cell rejection phenomenon. 
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The Chair then invited Cunningham to respond to the list of 
problems presented. Cunningham expressed his appreciation to the parti- 
cipants for their discussion of the diversity of problems and issues and 
noted that these would be taken into consideration in the further develop- 
ment of the UNDP/SF project. He noted that the field program in Kenya is 
underway, and that immune and susceptible cattle are being exposed to natural 
challenge at Kiboko. This field activity should lead to the identification 
of different strains of the parasite if these exist. As an illustration of 
the possible complicationswhichmight arise, he cited a case in which in 
1966 a buffalo was captured in the Serengeti and found to be infected with 
a Theilerial piroplasm. No previous contact by the buffalo with cattle 
was known. Nymphal ticks were fed on the buffalo. These ticks in becoming 
adults produced fatal Theilerial infection in cattle, but the disease could 
not then be transmitted through the tick, g. appendiculatus. Field out- 
breaks of similar buffalo derived Theileria in cattle have been recorded in 
East, Central and South Africa. These are likely to complicate any vaccina- 
tion programme. 
The Chairman then expressed appreciation to Cunningham, Moulton 
and others for m&king available to participants the wealth of information 
disclosed at the meeting, much of it pre-publication material. He summarised 
the priority problems requiring attention as follows, noting that these are 
not necessarily in order of priority. 
1. Irradiation variables 
2. Drugs and their dosages 
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Cunningham noted that with each of the four methods of immunisation 
described at least a further year's work is required, and he-expressed the 
interest of Pfizer in supporting further work of this nature. He noted that 
he has only tested one drug, using one dosage level and that there is a need 
to screen more drugs alone and in combinations and to use multiple treatments. 
3. Tissue culture and the production of cells for vaccine 
Cunningham noted that variables yet to be examined include age 
susceptibility of cattle, multiple inoculations and use of killed vaccine 
material from tissue culture. Quantity production of antigen is not a serious 
constraint, although quantities of foetal calf serum (FCS) required might be 
a constraint. A cheaper alternative to FCS would be advantageous. 
4. 
5. 
6. 
Harvesting of tick saliva 
Collection from ticks, harvesting of parasites for in vitro -- 
culture need to be improved. 
The growing of tick tissues and tick parasites 
Field epidemiology 
The role of related strains and related diseases such as 
have been encountered at Aitong. 
. 
7. 
8. 
9. 
10. 
11. 
Acceptance of cell lines 
Mechanism of immunity 
The preservation of live vaccine 
Concentration and distribution, and methods of field handling. 
Development of other antigens 
Pathogenicity 
Strain virulence and pathogenesis in the bovine host. 
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The Chairman noted that a number of these are receiving the 
attention of current workers and asked for the identification of those 
problems which are either not now receiving sufficient attention or those 
on which efforts should be greatly increased. 
Following further discussion it was agreed that each of the 
above required a substantial increase in effort. McKelvey expressed ap- 
preciation for the contributions made by participants noting that we may 
be perhaps half-way or even three-quarters towards the goal of a useful 
vaccine for ECF and toward setting the stage for the development of a vac- 
cine for trypanosomiasis. 
Sadun agreed but insisted that work on trypanosomiasis should 
not be delsyed pending solution to the above problems of ECF. 
Abdussalam suggested an expansion of the proposed institute's 
program to consider other problems in immunology. 
Muriithi suggested restricting the proposed institute's efforts 
to two problems, ECF and trypsnosomiasis. 
White reconfirmed his previous statements to the effect that the 
UNDP/SF project is affected by the proposal for a separate institute, that 
if there is assurance of an organisation to take up, expand and carry on 
the present work, that continued support for the current WDP/SF project 
might be more assured in the interim. 
McKelvey added that he would be hopeful that these discussions 
might culminate in an institute with program on the ground during the later 
part of 1973.. 
- 317 - 
Related Work - Trypsnosomiasis 
The Chairman invited Dr. Sadun to summarise the status of 
trypanosomiasis research. Sadun noted-that the priorities for trypano- 
somiasis work are identical to those agreed for ECF. He then described 
briefly the current state of work in Kenya and in Washington on trypano- 
somiasis. 
Ansari distributed to participants a paper entitled ilProposed 
UNDP/SF Regional Project for the establishment of an African Trypanoso- 
miasis Research Center" which would expand and consolidate the work and 
facilities of EATRO at Tororo, Uganda. 
An announcement was made later by Dr. Payne to the effect that 
notification of UNDP funding ~of the project presented by Ansari has been 
received. It was noted also that the International Institute for Insect 
Physiology and Ecology, University of i?airobi is to receive UNDP support 
for its work which ,includes a project on trypanosomiasis. 
The Chairman then conveyed his appreciation to the Convenor, 
the participants and to our FAO host and adjourned the meeting at 1745 on 
8 March 1971. 
._ 
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